Company Name:Grifols S.A.
CEO: Raimon Grifols Roura / VĂ­ctor Grifols Deu

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.


Key numbers

Market Capitalization:5596137929
Shares Outstanding: 258005436.99999997
Float: 253286259.551833
Next Earning Date:2020-02-27
TTm EPS: 0.9415
TTm Dividend Rate: 0.6239
200 days moving average:20.17
50 days moving average: 20.74
One day percent Change: 3.24



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,